Alopecia Areata Market Size and Share Analysis, Growth Opportunities, Current Treatment Practices, Emerging Therapies, Epidemiology Forecast | Key Companies – Incyte Corporation, Concert Pharma

 Breaking News
  • No posts were found

Alopecia Areata Market Size and Share Analysis, Growth Opportunities, Current Treatment Practices, Emerging Therapies, Epidemiology Forecast | Key Companies – Incyte Corporation, Concert Pharma

May 17
09:27 2022
Alopecia Areata Market Size and Share Analysis, Growth Opportunities, Current Treatment Practices, Emerging Therapies, Epidemiology Forecast | Key Companies - Incyte Corporation, Concert Pharma
Alopecia Areata Market

DelveInsight has launched a new report on “Alopecia Areata Market Insights, Epidemiology, and Market Forecast-2032”. 

DelveInsight’s “Alopecia Areata Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

 

Some of the key facts of the Alopecia Areata Market Report:

  • As per the National Organization for Rare Diseases, alopecia Areata is most common among the children and approximately 2.5 million people are suffering from alopecia Areata in the United States 
  • According to the studies, Alopecia Areata affects approximately two percent of the general population at some point during their lifetime 
  • According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and147 million worldwide have or will develop alopecia areata at some point in their lives
  • An estimated 2.4 million people visit a doctor in the United States for Alopecia Areata condition, which accounts for 25% of visits for all types of alopecia 

 

Request a sample for the Report: https://www.delveinsight.com/sample-request/alopecia-areata-market

 

Key benefits of the report:

  1. Alopecia Areata market report covers a descriptive overview and comprehensive insight of the Alopecia Areata Epidemiology and Alopecia Areata  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Alopecia Areata market report provides insights on the current and emerging therapies.
  3. Alopecia Areata market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Alopecia Areata market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market.

 

Got queries? Click here to know more about the Alopecia Areata Market Landscape 

 

Alopecia Areata Overview: 

According to the National Alopecia Areata Foundation, Alopecia Areata (AA) is a common autoimmune skin disease, which causes hair loss on the scalp, face, and at times other areas of the body. The affected hair follicles are attacked by a person’s immune system (white blood cells), which results in the seizing of the hair growth stage. Hair follicles remain alive, and hair can regrow at any time in Alopecia Areata. Alopecia Areata usually begins with one or more patches which may be small, round, and smooth on the scalp that can progress to total scalp hair loss or complete body hair loss. Genetic predisposition and environmental factors increase the chances of developing Alopecia Areata. 

People who develop Alopecia Areata can be of any age group, both sexes, and all ethnic groups. It often first appears during childhood and can be different for people who develop it. This autoimmune disorder is quite a common yet challenging and capricious disease. 

 

Alopecia Areata Symptoms:

The symptoms of Alopecia Areata include-

  • Abrupt hair loss
  • Gray and White hairs remain where the person sees hair loss
  • Hair loss occurs in the colder months 

 

In some cases, people experience more extensive hair fall, which is usually due to the other type of Alopecia Areata-

  • Alopecia totalis, which is loss of all scalp hair
  • Alopecia Universalis, which is the loss of entire body hair

 

Alopecia Areata Market  

The dynamics of the Alopecia Areata market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Baricitinib, CTP-543, Jacatinib, and others during the forecasted period 2019-2032. 

 

Learn more by requesting for sample @Alopecia Areata Market Landscape 

 

Alopecia Areata Pipeline Therapies:

  • Baricitinib
  • CTP-543
  • Jacatinib
  • TDM-105795
  • Etrasimod
  • Jacatinib hydrochloride

 

Alopecia Areata Pipeline Key Companies:

  • Incyte Corporation
  • Concert Pharmaceuticals
  • Suzhou Kintor Pharmaceutical 
  • Suzhou Zelgen Biopharmaceuticals
  • Arena Pharmaceuticals 

 

Table of Contents 

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Alopecia Areata Patient Share (%) Overview at a Glance

5. Alopecia Areata Market Overview at a Glance

6. Alopecia Areata Disease Background and Overview

7. Alopecia Areata Epidemiology and Patient Population

8. Country-Specific Patient Population of Alopecia Areata 

9. Alopecia Areata Current Treatment and Medical Practices

10. Unmet Needs

11. Alopecia Areata Emerging Therapies

12. Alopecia Areata Market Outlook

13. Country-Wise Alopecia Areata Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Alopecia Areata Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight 

 

Click here to read more about Alopecia Areata Market Outlook 2032

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/alopecia-areata-market

Categories